CANYON CAPITAL ADVISORS LLC - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 30 filers reported holding HORIZON PHARMA INVT LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
CANYON CAPITAL ADVISORS LLC ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q1 2019$5,691,000
-84.0%
5,000,000
-86.0%
0.14%
-83.7%
Q4 2018$35,592,000
+28.5%
35,600,000
+29.5%
0.84%
+122.8%
Q3 2018$27,693,000
-3.5%
27,500,000
-8.3%
0.38%
+18.2%
Q2 2018$28,712,000
+16.0%
30,000,000
+11.1%
0.32%
+27.6%
Q1 2018$24,761,000
-0.5%
27,000,0000.0%0.25%
-30.4%
Q4 2017$24,895,000
+2.1%
27,000,0000.0%0.36%
-1.6%
Q3 2017$24,384,000
+4.8%
27,000,0000.0%0.36%
-5.2%
Q2 2017$23,271,00027,000,0000.38%
Other shareholders
HORIZON PHARMA INVT LTD shareholders Q2 2017
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 144,832,000$191,529,0006.11%
SYMPHONY ASSET MANAGEMENT LLC 10,000,000$13,256,0002.93%
Nicholas Investment Partners, LP 4,380,000$5,784,0000.60%
Sonora Investment Management, LLC 4,725,000$6,258,0000.59%
CSS LLC/IL 7,836,000$10,420,0000.58%
SSI INVESTMENT MANAGEMENT LLC 6,397,000$8,448,0000.56%
Shaolin Capital Management LLC 2,500,000$3,323,0000.54%
MIZUHO SECURITIES USA LLC 5,000,000$6,635,0000.33%
ADVENT CAPITAL MANAGEMENT /DE/ 8,846,000$11,766,0000.23%
M&G INVESTMENT MANAGEMENT LTD 19,210,000$25,357,0000.22%
View complete list of HORIZON PHARMA INVT LTD shareholders